New Crypto Listings Recently | Today’s Viral Level= Wheat 2023-12-12
6.2BTC
16.21BTC
504.6BTC
1.17BTC
3.82BTC
1.32BTC
7.87BTC
222.82BTC
9.85BTC
3.16BTC
1.85BTC
1.79BTC
68.07BTC
1.84BTC
ChatGPT-4.0 developed by OpenAI has achieved a significant milestone at the intersection of artificial intelligence (AI) and medicine. ChatGPT-4.0, in a recent proof-of concept research, was able show its abilities by passing a neurology clinical test. It answered 85 percent of questions correctly. This remarkable performance was observed during an experiment conducted by researchers at the University Hospital Heidelberg, and the German Cancer Research Centre.
The clinical neurology test was created using information from the American Board of Psychiatry and Neurology and the European Board for Neurology. Its purpose is to evaluate the AI's level of expertise in this area. ChatGPT 4.0 scored higher than its predecessor ChatGPT 3.5 which had a score of only 66.8%. The average human score is 73.8%. This achievement shows that the model is highly skilled in areas associated with the cognitive, behavioural and psychological components of Neurology.
ChatGPT-4.0 is a successful model, but its performance has revealed some areas where it can be improved. Both variants of the model performed less well when compared to lower-order activities. This discovery fits in with the growing awareness of artificial intelligence in general, which recognizes that the models could improve in their cognitive abilities in the future.
The findings of this study could be used to guide the future integration of large language models, such as ChatGPT 4.0. These models, according to researchers, have the potential to contribute significantly to medicine if they are further modified and fine-tuned. The research also proposes applications for decision-making systems and documentation systems. However, it warns about their limitations in terms of the ability to perform high-order cognition tasks.
The findings of this study are more likely to serve as proof-of concept for LLMs rather than being immediately applicable in clinical settings. It is important to create and refine these models so that they can be used in clinical neurology. During the FIFA Club World CupTM 2023TM a unique combination of digital technology and football will be displayed via the NFT special series, which will be offered jointly by Modex and FIFA+ Collect. This series will improve the fan experience and enhance their interaction with the team.
VanEck is a prominent asset manager that has taken a major step forward by filing its fifth amended request for a Bitcoin Exchange-Traded Fund. This new move, dated 8 December 2023, marks an important chapter in the evolution and development of cryptocurrency investments.
The VanEck ETF will be listed with the ticker "HODL." The term "HODL" is commonly used by the Bitcoin community to describe a strategy in which investors hold on to Bitcoin and do not sell it. This strategy is consistent with the philosophy of Bitcoin enthusiasts who believe in enduring market volatility by holding on to their investments for a long time.
Market analysts have been paying close attention to the choice of "HODL" as a ticker. Nate Geraci of The ETF Store believes that this ticker is likely to resonate with cryptocurrency enthusiasts, but may be confusing for traditional investors. Eric Balchunas is the senior ETF analyst at Bloomberg Intelligence. He believes this approach is unique and unconventional, and different from other firms such as BlackRock and Fidelity.
VanEck's pursuit of an ETF that tracks Bitcoin spot is not unique. Other companies such as BlackRock, Fidelity Valkyrie and Franklin Templeton are also competing for approval by the United States Securities and Exchange Commission. The SEC is currently in active discussions with the firms involved to discuss technical aspects of these proposals. VanEck expects SEC approval of its spot Bitcoin ETF by January 2024. It also projects $2.4 billion to be inflowed in the first quarter after approval.
VanEck's decision to amend its application for a Bitcoin ETF with the ticker "HODL" is a strategic move to align itself with the ethos and values of the cryptocurrency community. This also highlights the growing interest in Bitcoin and its potential as an investment. The regulatory environment is constantly evolving, and the expectation of SEC approval shows the impact that such a product can have on the cryptocurrency markets.